Why the study?
Is simultaneous TEVAR and EVAR safe and effective in patients with concomitant thoracic and abdominal aortic pathologies?
Is simultaneous TEVAR and EVAR safe and effective in patients with concomitant thoracic and abdominal aortic pathologies?
Simultaneous TEVAR and EVAR appears technically feasible and safe for patients with multilevel aortic diseases, with a 100% technical success rate in this small single-center series.
No takes yet. Share an insight, caveat, or question.
Supports feasibility in select multilevel aortic cases; leaves open long-term safety and efficacy in larger studies.
Zeng et al. (2016) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: